Overview
Mobile technology has been one of the largest contributors to big data for the past several years. The implementation of app-enabled smart phones and now the growth of the wearable device market are all creating massive new data flows that can be put to use for health and other purposes. Join our deep tech entrepreneurs as we discuss how wearables and data insights are delivering better care to all.
Date : 31 August 2018, Friday
Time : 10:00am 12:00pm
Venue : 32 Carpenter Street, Singapore 059911
Programme:
10:00am 10:30am: Registration
10:30am 11:30am: Better Care with Data and Wearables
11:30pm 12:00pm: Q&A and Networking
Speakers:
- Amrish Nair, CEO and Co-Founder, Biorithm
- Rami Alhamad, CEO, PUSH
- Kuldeep Singh Rajput - Founder & Chief Executive Officer, Biofourmis Group
Moderator:Julien de Salaberry, CEO and Founder, Galen Growth Asia
Speakers' Profiles:
Amrish Nair, CEO & Co-Founder, BIORITHM
Born and raised in Singapore, Amrish Nair received his B.Eng. and M.Eng. from the School of Electrical and Electronic Engineering at the Nanyang Technological University.
His graduate studies research led him to numerous international publications and a US Patent on ECG signal analysis and monitoring.
His research collaboration with TTSH cardiologist, Dr. David and NTU supervisor Assoc. Prof. Pina Marziliano led him to spin-off BIORITHM, a medtech startup, where he has been CEO since 2015.
Having successfully received research grants and participated in international accelerators, BIORITHM is gaining traction in the area of remote monitoring.
Rami Alhamad,CEO, PUSH
Founder of Push, Rami's true passions lie at the intersection of sport and technology. Motivated by his own experiences as an athlete and witnessing the potential that technology can unlock in sport and athletes at all levels, Rami set out on his journey to launch Push in 2013 and hasn't looked back since. Push's products are now in active use by over 38 pro teams across all major sports as well as in training facilities that are busy developing tomorrow's elite athletes.
Rami has a degree in Mechatronics Engineering from the University of Waterloo and a Master's degree in Engineering Systems and Computing from the University of Guelph. He has played rugby competitively and you can find him in the gym or running on the streets of Toronto.
Kuldeep Singh Rajput,Founder & Chief Executive Officer, Biofourmis Group
Kuldeep Singh Rajput is the Founder and Chief Executive Officer of Biofourmis, a fast-growing digital health start-up that has developed an AI-empowered health analytics platform based on human physiology, which uses readily available wearable biosensors, EMR data and mobile technologies to predict health exacerbation days in advance before a critical event. Named as the “Most Innovative HealthTech Startup in Asiaâ€, the company is backed by leading Venture Capital firms including Openspace Ventures, Aviva Ventures the venture capital arm of leading global insurer, Aviva plc, SGInnovate, Mayo Clinic Ventures and SpesNet Group. Their approach has been embraced by leading client/partners including SingHealth, Mayo Clinic, Brigham and Women's Hospital, Aviva plc, Mundipharma etc.
Kuldeep is an active member of the healthcare innovation and entrepreneurship community in Singapore, with a specific interest in technology-enabled healthcare innovation. During his Ph.D. studies at the National University of Singapore (NUS), he was building bioelectronics implants, which aim to control biological processes and treat diseases by modulating electric impulses. Prior to moving to Singapore, he was a researcher at MIT Media Lab, where he was working on building diagnostic algorithms to detect various cardiac conditions like arrhythmias and sleep apnoea's in partnership with Massachusetts General Hospital. Kuldeep has been invited to speak at some prestigious events on how they are augmenting personalized care using digital therapeutics at TEDx, American College of Cardiology Conference (ACC 2018), SwissRe Health Monitoring in Insurance, HIMSS etc.
Moderator's Profile:
Julien de Salaberry, CEO and Founder, Galen Growth Asia
Julien is the CEO and founder of Galen Growth Asia which has built a portfolio of solutions which creates a significant financial and social value multiplier through direct collaboration between enterprise, startups and investors to prototype, evaluate and implement HealthTech (aka digital health) solutions to solve healthcare system pain points.
With its mandate as the regional ecosystem builder, Galen Growth Asia sits at the epicentre of it and works closely with enterprise, investors and startup ventures.
Julien is also the founder of The Propell Group, an early-stage venture investor and advisory firm, based in Singapore, focused on HealthTech innovation. He has over 15 years of experience in healthcare with leading brands including Eli Lilly, Boston Scientific, Baxter, GSK, Merck&Co.
